Mixed
In Chinese patients with type 2 diabetes, obesity (BMI ≥28 kg/m²) and central obesity are significantly associated with a lower likelihood of achieving integrated cardiometabolic therapeutic goals (HbA1c <7%, BP <140/90 mmHg, LDL-C <2.6 mmol/L) compared to normal-weight patients, even when receiving more intensive pharmacotherapy.
If you have type 2 diabetes, achieving blood sugar, blood pressure, and cholesterol targets is significantly harder if you are obese, even if you are taking more medication than thinner patients. The study suggests that weight loss is a critical component of treatment that medication alone cannot replace. Focus on weight management strategies alongside your prescribed medications to improve your chances of reaching health goals.
Obesity is highly prevalent and associated with poor 3B control in Chinese type 2 diabetes patients... In multivariate logistic regression analysis, higher BMI and waist circumference... were significantly correlated with failure to achieve 3B control goals.
Why this rating
Large cross-sectional observational study (n=24,512) with rigorous statistical adjustment, though causality is limited by cross-sectional design.
Source
Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study
Xianghai Zhou et al. · PLoS ONE · 2016
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →